FDA investigates diabetes drug metformin for NDMA carcinogen
FDA investigates diabetes drug metformin for NDMA carcinogen
Reuters: Health
The U.S. Food and Drug Administration said on Thursday it was investigating whether metformin diabetes medicines sold in the United States contain unsafe levels of a carcinogen called NDMA.
No comments:
Post a Comment